Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series
Immune checkpoint inhibitors (ICIs) are established treatments for various malignancies, including lung, kidney, and colorectal cancers. However, their broad use has led to an increase in immune-related adverse events (irAEs), with thyroiditis, colitis, and pneumonitis being the most common. Hemopha...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Open Exploration Publishing Inc.
2025-11-01
|
| Collection: | Exploration of Targeted Anti-tumor Therapy |
| Sujets: | |
| Accès en ligne: | https://www.explorationpub.com/uploads/Article/A1002347/1002347.pdf |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|